Europe Branded Generics Market Size, Share & Trends Analysis Report By Drug Class (Alkylating Agents, Antimetabolites), By Application, By Route Of Administration, By Distribution Channel, By Country, And Segment Forecasts, 2023 - 2030
- Report ID: GVR-4-68040-014-9
- Number of Pages: 105
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- Europe Branded Generics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Europe Branded Generics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Europe Branded Generics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Topical
- Oral
- Parenteral
- Others
- Europe Branded Generics Distribution Channel Outlook (Revenue, USD Million, 2018 – 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others
- Europe Branded Generics Regional Outlook (Revenue, USD Million; 2018 - 2030)
- Europe
- Europe branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Europe branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Europe branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Europe branded generics market, by distribution channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others
- UK
- UK branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- UK branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- UK branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- UK branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- UK branded generics market, by drug class
- France
- France branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- France branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- France branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- France branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- France branded generics market, by drug class
- Russia
- Russia branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Russia branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Russia branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Russia branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Russia branded generics market, by drug class
- Germany
- Germany branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Germany branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Germany branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Germany Europe branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Germany branded generics market, by drug class
- Italy
- Italy branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Italy branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Italy branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Italy branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Italy branded generics market, by drug class
- Spain
- Spain branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Spain branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Spain branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Spain branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Spain branded generics market, by drug class
- Denmark
- Denmark branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Denmark branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Denmark branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Denmark branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Denmark branded generics market, by drug class
- Sweden
- Sweden branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Sweden branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Sweden branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Sweden branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Sweden branded generics market, by drug class
- Norway
- Norway branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Norway branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Norway branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Norway branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Norway branded generics market, by drug class
- Rest of Europe
- Rest of Europe branded generics market, by drug class
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive & Lipid lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Rest of Europe branded generics market, by application
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Rest of Europe branded generics market, by route of administration
- Topical
- Oral
- Parenteral
- Others
- Rest of Europe branded generics market, by distribution channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy & Others
- Rest of Europe branded generics market, by drug class
- Europe branded generics market, by drug class
- Europe
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
